-
Wockhardt divests nutrition business
MUMBAI, India — Indian generic drug maker Wockhardt will sell its nutrition business to France's Danone, the company said Tuesday.
The deal is worth $355 million, according to published reports, and includes brands like Farex, Dexolac, Nusobee and Protinex.
Wockhardt said the deal was part of a strategy to consolidate and rationalize its core operations and focus on its pharmaceutical business. -
Topco institutes OTC substitution program for generic Rx
SKOKIE, Ill. — Topco, a member-owned cooperative serving the food industry, recently kicked off an initiative substituting its TopCare-branded over-the-counter medicines for the equivalent prescription pharmaceutical, where appropriate, in an effort to save patient dollars and promote the TopCare brand.